Potential therapeutic effect of pomegranate seed oil on ovarian ischemia/reperfusion injury in rats.

Iran J Basic Med Sci

Department of Histology and Embryology, Ataturk University, Faculty of Medicine, 25240 Erzurum/Turkey.

Published: December 2018

Objectives: The aim of this study is to determine the therapeutic effects of pomegranate seed oil, which is a powerful antioxidant and anti-inflammatory agent, on ovarian-ischemia and reperfusion injury in rats.

Materials And Methods: Fifty-six female albino Wistar rats were divided into 7 equal groups. Group 1; Sham Operation, Group 2; Ischemia, Group 3; Ischemia + Reperfusion, Group 4; Ischemia + Pomegranate 0,32 ml / kg (IP), Group 5; Ischemia + Pomegranate 0.64 ml / kg, Group 6; Ischemia + Pomegranate 0,32 ml / kg + reperfusion, Group 7; Ischemia + Pomegranate 0,64 ml / kg + reperfusion. Three hours after ischemia and 3 hours after reperfusion, the study was terminated.

Results: While NADPH oxidase activity, MDA and TNF-α levels were significantly increased, SOD activity and GSH levels were reduced in ischemia and I/R groups. Low dose pomegranate seed oil application reduced significantly oxidative stress and NADPH oxidase activity in both ischemic and ischemic/reperfusion groups. At the same time, low-dose pomegranate seed oil extract reduced TNF-α levels and significantly increased antioxidant activity.

Conclusion: PSO demonstrated an important therapeutic effect in the treatment of ovarian ischemia and reperfusion injury.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312678PMC
http://dx.doi.org/10.22038/ijbms.2018.30149.7268DOI Listing

Publication Analysis

Top Keywords

group ischemia
24
pomegranate seed
16
seed oil
16
ischemia pomegranate
16
ischemia
9
pomegranate
8
reperfusion injury
8
ischemia reperfusion
8
reperfusion group
8
pomegranate 032
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!